Results 1 -
10
of
23
for
physical therapy
- ... L, Simmonds JV. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with ...
- ... LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with ...
- ... LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with ...
- ... treatments might improve some symptoms. These treatments include physical and speech therapy and improving deficits in the immune system and ...
- ... polymorphic ventricular tachycardia: a model for genotype-specific therapy. Curr Opin Cardiol. 2017 Jan;32(1):78- ... van der Werf C, Zwinderman AH, Wilde AA. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: ...
- ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... in the decrease in blood cells and the physical differences that are seen in people with Fanconi ...
- ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... bone marrow function, an increased cancer risk, and physical differences. Variants in the FANCA gene are responsible ...
- ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... bone marrow function, an increased cancer risk, and physical differences. About 10 percent of all cases of ...
- ... Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies. Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1: ...
- ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... bone marrow function, an increased cancer risk, and physical differences. Variants in the FANCC gene are responsible ...